Jim Cleffi is a Managing Director with Alvarez & Marsal’s Life Sciences Practice in Philadelphia. He specializes in transformational strategies focused on business growth, commercial models, M&A and customer strategies. His specialization in healthcare provider, health start-ups and products businesses enables him to work across the healthcare ecosystem with a focus on growth and stakeholder value.

Mandy Coffey is a Senior Director with Alvarez & Marsal’s Licensing Advisory Services in Houston. With over 15 years of experience in public accounting, she is a leader in the license advisory space.

Daaron Dohler is a Senior Director with Alvarez & Marsal’s Life Sciences Practice in Chicago. He brings more than 25 years of cross-functional experience in the global pharmaceutical and biotech industry.

Mark Freitas is a Managing Director and Life Sciences Practice Leader with Alvarez & Marsal Healthcare’s Industry Group in Boston. With over two decades of proven expertise, he is passionate about helping businesses reach their full potential and has developed successful strategies that maximize growth while avoiding operational pitfalls.

James Guyton is a Managing Director with Alvarez & Marsal Life Sciences in Washington, D.C. He is known for performance improvement in life sciences companies, helping clients improve profitability, drive growth, and deliver products and services to meet patient needs. He specializes in pharmaceuticals, biologics, vaccines, medical devices, diagnostics, contract services, distributors, and digital health.

Gayla Langlois is a Senior Director with Alvarez & Marsal’s Insight Center in Boston.

Frank Orlowski is a Managing Director with Alvarez & Marsal’s Life Sciences practice in New York. He specializes in cost optimization, global growth strategies product financial modeling and all sized M&A transactions, including joint ventures, alliance partnerships and milestone transactions, along with traditional M&A.

Matthew Sheldon is a Managing Director with Alvarez & Marsal’s Life Sciences Practice in Boston. He brings extensive experience in advanced analytics, commercial growth strategy development, patient-centered solution design, market assessment and valuation, operational effectiveness improvement, risk management, and financial modeling and forecasting.